OpenVSafe by OpenVAERS
Search V-safe

XU6-27778-60104

4 vaccinations 11 coded responses 17 check-ins 10 free-text entries 0 call cases
Sex
Female
Age at first dose
21-25
ZIP prefix
302 / GA
Registered
2022-01-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-17
    Dose 2 — Pfizer-BioNTech
  3. 2022-01-16
    Dose 3 — Pfizer-BioNTech
  4. 2022-01-18
    Registered in v-safe
  5. 2022-01-18
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cardiac flutter, Chest pain, Dyspnoea — Feeling: Poor · Site: Pain, Redness, Swelling, Itching · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  6. 2022-01-21
    Survey response — days 1–6 daily, dose 3
    MedDRA: Cardiac flutter, Chest pain, Dyspnoea — Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Headache, Fatigue or tiredness · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  7. 2022-01-23
    Survey response — 7 day, dose 3
    MedDRA: Cardiac flutter — Feeling: Fair · Fever · Chills, Headache, Fatigue or tiredness
    MedDRA releases: 2024-11 · check-in answers available
  8. 2022-01-30
    Health check-in — 14 day, dose 3
    Feeling: Good
    Adult check-in
  9. 2022-02-06
    Health check-in — 21 day, dose 3
    Feeling: Good
    Adult check-in
  10. 2022-02-13
    Health check-in — 28 day, dose 3
    Feeling: Good
    Adult check-in
  11. 2022-02-20
    Health check-in — 35 day, dose 3
    Feeling: Good
    Adult check-in
  12. 2022-02-27
    Health check-in — 42 day, dose 3
    Feeling: Good
    Adult check-in
  13. 2022-04-18
    Survey response — 3 month, dose 3
    MedDRA: Heart rate increased, Nausea, Vomiting — Feeling: Fair · Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  14. 2022-07-17
    Health check-in — 6 month, dose 3
    Feeling: Good
    Adult check-in
  15. 2022-09-13
    Dose 4 — Pfizer-BioNTech
  16. 2022-09-23
    Survey response — 7 day, dose 4
    MedDRA: Cardiac flutter, Chest pain, Dizziness, Dyspnoea, Gastrooesophageal reflux disease, Heart rate increased, Insomnia, Phantom limb syndrome — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  17. 2022-09-27
    Survey response — 14 day, dose 4
    MedDRA: Blood pressure ambulatory increased, Chest pain, Cold sweat, Decreased appetite, Dizziness, Dyspnoea, Fatigue, Gait inability, Headache, Hyperhidrosis, Nausea, Pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  18. 2022-10-06
    Survey response — 21 day, dose 4
    MedDRA: Back pain, Chest pain, Dizziness, Dyspnoea, Emergency care, Headache, Heart rate increased, Hyperhidrosis, Nausea, Neck pain, Pain, Palpitations, Paraesthesia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  19. 2022-10-13
    Survey response — 28 day, dose 4
    MedDRA: Back pain, Chest pain, Dyspnoea, Headache, Neck pain, Pain, Sleep disorder — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  20. 2022-10-18
    Survey response — 35 day, dose 4
    MedDRA: Back pain, Electric shock sensation, Paraesthesia — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  21. 2022-10-26
    Survey response — 42 day, dose 4
    MedDRA: Abdominal pain, Chest pain, Pain, Pain in extremity — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available
  22. 2023-03-15
    Survey response — 6 month, dose 4
    MedDRA: Neck pain, Painful respiration, Pericarditis — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    MedDRA releases: 2024-11 · check-in answers available

Vaccinations

DoseDateManufacturerCo-administered
12021-03-27Pfizer-BioNTech No
22021-04-17Pfizer-BioNTech No
32022-01-16Pfizer-BioNTech No
42022-09-13Pfizer-BioNTech No

Free text

Release 10

Systemic reaction (other): Chest pain, shortness of breath, heart fluttering

Release 11

Systemic reaction (other): Chest pain, shortness of breath, heart fluttering

Systemic reaction (other): Heart fluttering

Symptoms: Nausea, vomiting, heart rate increase

Release 12

Systemic reaction (other): Chest pain, heart fluttering, acid reflux, dizziness, shortness of breath, inconsistent extremely elevated and lowered heart rate, insomnia, phantom pains

Symptoms: Severe sharp chest pain, shortness of breath, inability to move without bpm immediately jumping to 190, dizziness, nausea, headaches, zero appetite, fatigue, sweaty clammy hands, unable to lie down or stand up without pain. Unable to walk bc of heart cut off by CDC

Symptoms: 5 ER visits for dizziness, pounding heart, nausea, sweating, hand sweating, tingling in all 4 limbs, constant chest pain that periodically radiates from left of chest to left upper back, neck, and head, heartrate of up to 190 bpm, shortness of breath cut off by CDC

Symptoms: All of previously listed plus chest pain has moved to center of chest and become very severe, & is still radiating to left arm, upper back, and neck. Center of chest pain is so severe it wakes me up at night frequently. Shortness of breath, headaches cut off by CDC

Symptoms: All previous symptoms, plus new electric tingling feeling down arm and widened upper back pain

Symptoms: Both posterior thighs are now severely sore with sharp chest pain that is radiating to my abdomen. All previously noted symptoms still present.

Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal pain · · ✓
SDBack pain · · ✓
SDBlood pressure ambulatory increased · · ✓
SDChest pain · · ✓
SDCold sweat · · ✓
SDDecreased appetite · · ✓
SDDizziness · · ✓
SDDyspnoea · · ✓
SDElectric shock sensation · · ✓
SDEmergency care · · ✓
SDFatigue · · ✓
SDGait inability · · ✓
SDHeadache · · ✓
SDHeart rate increased · · ✓
SDHyperhidrosis · · ✓
SDNausea · · ✓
SDNeck pain · · ✓
SDPain · · ✓
SDPain in extremity · · ✓
SDPainful respiration · · ✓
SDPalpitations · · ✓
SDParaesthesia · · ✓
SDPericarditis · · ✓
SDSleep disorder · · ✓
SDVomiting · · ✓
SROCardiac flutter · · ✓
SROChest pain · · ✓
SRODizziness · · ✓
SRODyspnoea · · ✓
SROGastrooesophageal reflux disease · · ✓
SROHeart rate increased · · ✓
SROInsomnia · · ✓
SROPhantom limb syndrome · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release